Lymphoma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Children between 2 and 10 years of age
- Children who have been medically diagnosed with a type of blood cancer called acute lymphoblastic leukemia (ALL) and are currently receiving chemotherapy that includes a steroid medication (dexamethasone) as part of their maintenance treatment phase
- Children whose doctor considers them medically stable and well enough to take part in gentle, low-intensity yoga movements
- Families where at least one parent or legal guardian is willing and able to be present and involved in the home-based sessions with the child
- Families where a parent or legal guardian is able to provide written consent to participate, and where the child is able to give their agreement in an age-appropriate way
Who may not be able to join:
- Children who have had a major surgery in the past 2 weeks that may affect their ability to safely take part in gentle activity
- Children with serious, uncontrolled medical conditions — such as unstable vital signs, uncontrolled heart or breathing problems, or uncontrolled epilepsy — that could put them at risk during light movement or laughter exercises
- Children with severe difficulties with vision, hearing, or understanding that would prevent them from following along with video-based instructions and exercises
- Children with physical limitations or injuries to muscles or joints that would prevent participation in the activities
- Children with any other condition that, in their treating doctor's judgment, would make safe participation or ongoing involvement difficult
- Children who are already enrolled in another interventional clinical trial focused on pain management
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Bahaa W Bou Dargham, MD, Beirut Arab University and Hammoud Hospital University Medical Center
Phone: +9613537986
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Mean Pain Intensity on Days 5 and 6
Can't join this trial?
Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.